NCT01395485View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Asthma

Interventions

DRUG

AMG 827 or Placebo

A single dose of AMG 827 or matching placebo is to be administered subcutaneously (SC).

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY